The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
New article from PharmaTox summarises the research on prenatal medication exposure and offspring epigenetic outcomes
June 22, 2021 8:38 PM
A new literature review on genetic teratology from PharmaTox and the Federal University of Rio Grande do Sul
June 8, 2021 12:00 AM
New International Partnerships for Excellent Education, Research and Innovation (INTPART) project funded !
May 14, 2021 11:28 AM
The project is called "International Alliance for PharmacoGenetic Epidemiology Excellence (iAPOGEE)", and is led by Hedvig Nordeng, Department of Pharmacy.
PharmaTox yearly report 2020
Feb. 1, 2021 10:45 AM
Read the PharmaTox yearly report to see what PharmaTox researchers achieved in 2020!
Emil Aas Stoltenberg will defend his PhD October 30th! Save the date!
Oct. 29, 2020 10:43 AM